Treace Medical Concepts (TMCI) is jumping 7.5% after investment bank BTIG upgraded the shares to Buy from Neutral. Why BTIG ...

Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical Concepts (TMCI – Research Report) to a Buy today and set a price target of $16.00. The ...

Treace Medical Concepts, Inc.’s TMCI share price has surged by 10.21%, which has investors questioning if this is right time to sell.

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, reaching US$458.4 ...

Treace Medical Concepts Trading Up 5.6 % NASDAQ TMCI opened at $8.71 on Friday. Treace Medical Concepts, Inc. has a one year low of $3.92 and a one year high of $15.98. The firm has a market cap ...

Major medical health insurance is a type of health insurance that covers the expenses associated with serious illness or hospitalization. When choosing a health plan, it's important to understand what ...

Treace Medical (TASE:PMCN) Concepts (TMCI), a company specializing in foot and ankle orthopedics, reported an 11% increase in third-quarter revenue, amounting to $45.1 ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.